How PMCHS research is organized: the model's hypotheses, the predictions that follow from them, and the progress of ongoing work.
This research started from a specific question raised in February 2026: could mast cells play a role in sudden infant death syndrome? It has since grown into a broader framework — the Programmed Mast Cell Hyperreactivity Syndrome (PMCHS) — documented by two preprints, an international survey (N=423), and ongoing presentation and exchange with the scientific community.
This section of the site organizes the research into three parts: the hypotheses the current model rests on, the testable predictions that follow from them, and ongoing work — conferences, research notes, and next steps.